Ischemic Stroke
Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.
Subtype terms (2)
More specific conditions that are subtypes of Ischemic Stroke in the MeSH hierarchy.
- Embolic Stroke
12 drugs (8 approved, 4 experimental)
- Thrombotic Stroke
2 drugs experimental
Drugs by status
Approved for this indication (4)
Phase 4 trials (65)
- simvastatin
- ezetimibe
- melatonin
- edoxaban
- allopurinol
- heparin
- methylprednisolone
- agomelatine
- argatroban
- dabigatran
- fimasartan
- porcine brain-derived peptide preparation
- atenolol
- fluvastatin
- edaravone
- prednisone
- ginseng
- probucol
- tenecteplase
- amlodipine
- rosuvastatin
- Huatuo Zaizao
- insulin human
- warfarin
- labetalol
- monosialoganglioside
- naoxintong
- nicardipine
- evolocumab
- atorvastatin
- +35 more
Phase 3 trials (78)
- metformin
- phenylephrine
- 3k3a-apc
- dalfampridine
- nitroglycerin
- angongniuhuang
- buspirone
- bng-1
- norepinephrine
- ketamine
- esmolol
- alpha-lipoic acid
- Lumbricus rubellus
- dm199
- dp-b99
- galantamine
- gabapentin
- paclitaxel
- liraglutide
- albumin (Human)
- fibrinogen (human)
- hydralazine
- hydrogen
- xenon-129
- eptifibatide
- cobalamin
- levodopa
- meperidine
- memantine
- Emoxypine
- +48 more
Phase 2 trials (108)
- mannitol
- ringer's lactate
- sarecycline
- riociguat
- afamelanotide
- alfimeprase
- vitamin e
- acetylcysteine
- maraviroc
- azd6482
- beetroot juice
- epoetin
- Milvexian
- bu-yang-huan-wu tang
- tadalafil
- cinepazide
- citalopram
- exenatide
- conestat alfa
- cromoglicic acid
- deferoxamine
- Desmoteplase
- dimethyl fumarate
- valproic acid
- dornase alfa
- ds-1040b
- hydroxypropyl-beta-cyclodextrin
- glyburide
- bone marrow derived mesenchymal stem cells
- ht-3951
- +78 more
Phase 1 trials (32)
- bms 986141
- chlorpromazine
- diltiazem
- icosapent ethyl
- ils-920
- kallikrein
- lu aa24493
- pegylated carboxyhemoglobin
- magnesium sulfate
- immune globulin (human)
- verapamil
- endothelial progenitor cells
- sildenafil
- isa-51
- psilocybin
- promethazine hydrochloride
- exosomes from mesenchymal stem cells
- selenium
- nsi-566
- np10679
- magnesium
- Neural Stem Cell-Derived Neurons
- aer-271
- nts-104 tris
- sp-8356
- da414
- extracellular vesicles derived from human induced neural stem cell
- hnpc01
- es2b-c001
- hrs-4029
- +2 more
Other trials (32)
- levofloxacin
- deng zhan sheng mai
- troponin
- cocoa bean
- palmitoylethanolamide
- sevoflurane
- escitalopram
- ozone
- ixeris of sonchifolia hance
- apolipoprotein c1
- dipyridamole
- sanchi-tongshu
- sivelestat
- sodium oligo-mannurarate
- xiaoyao
- coumarin
- ramipril
- autologous bone marrow derived mesenchymal cells
- creatine
- luteolin
- shuxuetong
- hydrochlorothiazide
- venlafaxine
- chlorhexidine
- remifentanil
- vitamin k2
- zinc
- Collagen Tripeptide
- ruyizhenbao
- yangxue qingnao
- +2 more